Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Are you a current or former college athlete
Inflammation may help explain how GLP-1 drugs prevent AFib New research presented at Heart Rhythm 2026 suggests taking GLP-1 receptor agonists (GLP-1-RAs) may reduce the risk of atrial fibrillation (AFib) and improve survival through mechanisms that extend beyond weight loss alone
Per: Importado por: TECNOFARMA S.A
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Mild injection-site reactions Transient hunger (mild) Rare water retention Rare mild flushing Known interactions Concurrent rhGH not recommended Insulin / glucose-lowering agents (mild hyperglycemia possible) Contraindications Active malignancy Pituitary tumor Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved
Dosing Schedule We start low and increase gradually to minimize side effects
US$ 22.12
US$ 25.45
US$ 28.25
